Back to List View Graph View

Vancomycin

Vancomycin is a glycopeptide antibiotic used primarily for serious infections caused by gram-positive bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA).

Where the papers sit

15 papers from the last 6 months study vancomycin directly · updated from PubMed 16 Nov 2026

Study type 0 clinical trials · 2 observational · 3 human data · 9 preclinical · 1 unclassified

Themes 3 themes

  • Vancomycin Therapeutic Monitoring

    Vancomycin use is moving toward individualized monitoring that combines rapid sensing, interstitial-fluid sampling and population pharmacokinetic modeling. Machine learning is being applied to select pharmacokinetic models and improve dose selection, while molecularly imprinted sensors and microneedle patches seek less invasive concentration measurements. Delivery studies add sustained release from bone grafts and injectable hydrogels to the optimization agenda. DRESS and antimicrobial-resistance findings keep systemic safety and alternatives to vancomycin in view.

    9 papers · 60%

  • Targeted Antibacterial Nanoformulations

    Local vancomycin delivery is moving toward multifunctional platforms that combine sustained antibacterial activity with anti-inflammatory effects. Nanozyme hydrogels, MXene systems, cerium-based MOF coatings and intranasal sprays target difficult sites including joints, implants and the brain. Recurring goals are bacterial trapping or killing, controlled release and reduced tissue damage in infections caused by Staphylococcus aureus and other pathogens. Septic arthritis, endophthalmitis and pneumococcal colonization remain the main clinical endpoints.

    4 papers · 26.7%

  • Vancomycin-Associated Kidney Injury

    Acute kidney injury is the central concern when vancomycin is combined with broad-spectrum β-lactam antibiotics. The recurring comparison is vancomycin plus piperacillin/tazobactam versus vancomycin with cefepime or meropenem. Retrospective analyses use kidney-injury incidence and odds ratios to quantify the excess risk. The evidence supports careful selection of companion antibiotics, although the optimal regimen remains a clinical question.

    2 papers · 13.3%

vancomycin chemical structure

Papers

The 15 papers from the last 6 months that study vancomycin directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Vancomycin Therapeutic Monitoring (9)
  1. Vancomycin elution from gamma-irradiated cancellous bone allograft: an in vitro study linking soaking concentration to clinically relevant antimicrobial thresholds. Cell and tissue banking · 8 Oct 2026 PMID 42850457
  2. Development of a method for vancomycin monitoring in interstitial fluid using a novel porous microneedle array patch. Drug metabolism and pharmacokinetics · 7 Sept 2026 PMID 42704964
  3. Development and validation of machine learning model for selecting the optimal population pharmacokinetic model for vancomycin. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 26 Aug 2026 PMID 42648633
  4. An integrated system of micromixers and microfluidic concentration gradient chips assisted drug screening over large concentration range. Mikrochimica acta · 18 Jul 2026 PMID 42471438
  5. Lubricin-Protected Plasmonic Nanoslides Enable Stable, Reusable, Nonfouling, and Ultrasensitive Biomimetic-SERS Sensing for the Detection of Vancomycin in Unprocessed Whole Blood. Nano letters · 1 Jul 2026 PMID 42381442
  6. Injectable vancomycin-conjugated polysaccharide-protein hydrogel for targeted antibacterial therapy in musculoskeletal infections. International journal of biological macromolecules · 23 Jun 2026 PMID 42336007
  7. All-Hydrocarbon Stapling and Amino Acid Substitution-Modified Antimicrobial Peptide Feleucin-K3 Analogs Enhanced the Stability and Optimized the Therapeutic Index against Multidrug-Resistant Bacteria. Journal of medicinal chemistry · 9 Jun 2026 PMID 42262908
  8. DRESS'ed in Shock and Delay in Eosinophilia Resolution: Management Dilemmas in a Complex Case of Vancomycin-Induced DRESS Syndrome. The American journal of case reports · 23 May 2026 PMID 42175544
  9. Machine Learning-Assisted Molecularly Imprinted Polymer Sensor for Point-of-Care Vancomycin Monitoring in Serum. ACS applied bio materials · 21 May 2026 PMID 42166153
Targeted Antibacterial Nanoformulations (4)
  1. A TiVCrMoC3 MXene-Based Sustained-Release Vancomycin Nanoplatform Mitigates Septic Arthritis through Modulation of Bacterial Acetate Metabolism. ACS applied materials & interfaces · 2 Nov 2026 PMID 42968435
  2. An Injectable Dual Bacterial-Trapping Nanozyme Composite Hydrogel for Synergistic Antibacterial/Anti-Inflammatory Therapy of Endophthalmitis. ACS applied materials & interfaces · 6 Aug 2026 PMID 42561041
  3. A "three-in-one" nose-to-brain delivery strategy: intranasal vancomycin spray achieves simultaneous clearance of pneumococcal colonization, bacteremia, and meningitis. International journal of pharmaceutics · 4 Jul 2026 PMID 42401303
  4. Ultrasmall pH-triggered cerium-based MOF nanozyme delivery system: Stable implant coating with integrated synergistic antibacterial and corrosion resistance enhancement. Colloids and surfaces. B, Biointerfaces · 29 Jun 2026 PMID 42372462
Vancomycin-Associated Kidney Injury (2)
  1. Risk of acute kidney injury in patients on concomitant vancomycin and piperacillin-tazobactam compared to vancomycin and other beta-lactam agents: a large multicenter retrospective cohort study from China. Microbiology spectrum · 6 Jul 2026 PMID 42405788
  2. The impact of vancomycin and piperacillin-tazobactam combination therapy on the incidence of acute kidney injury: a retrospective review. Proceedings (Baylor University. Medical Center) · 10 Jun 2026 PMID 42269076

By study type

Observational studies and case reports (2)
  1. The impact of vancomycin and piperacillin-tazobactam combination therapy on the incidence of acute kidney injury: a retrospective review. Proceedings (Baylor University. Medical Center) · 10 Jun 2026 PMID 42269076
  2. DRESS'ed in Shock and Delay in Eosinophilia Resolution: Management Dilemmas in a Complex Case of Vancomycin-Induced DRESS Syndrome. The American journal of case reports · 23 May 2026 PMID 42175544
Human data, design not indexed (3)
  1. Development and validation of machine learning model for selecting the optimal population pharmacokinetic model for vancomycin. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 26 Aug 2026 PMID 42648633
  2. Lubricin-Protected Plasmonic Nanoslides Enable Stable, Reusable, Nonfouling, and Ultrasensitive Biomimetic-SERS Sensing for the Detection of Vancomycin in Unprocessed Whole Blood. Nano letters · 1 Jul 2026 PMID 42381442
  3. Machine Learning-Assisted Molecularly Imprinted Polymer Sensor for Point-of-Care Vancomycin Monitoring in Serum. ACS applied bio materials · 21 May 2026 PMID 42166153
Preclinical: animal, cell and lab studies (9)
  1. A TiVCrMoC3 MXene-Based Sustained-Release Vancomycin Nanoplatform Mitigates Septic Arthritis through Modulation of Bacterial Acetate Metabolism. ACS applied materials & interfaces · 2 Nov 2026 PMID 42968435
  2. Vancomycin elution from gamma-irradiated cancellous bone allograft: an in vitro study linking soaking concentration to clinically relevant antimicrobial thresholds. Cell and tissue banking · 8 Oct 2026 PMID 42850457
  3. Development of a method for vancomycin monitoring in interstitial fluid using a novel porous microneedle array patch. Drug metabolism and pharmacokinetics · 7 Sept 2026 PMID 42704964
  4. An Injectable Dual Bacterial-Trapping Nanozyme Composite Hydrogel for Synergistic Antibacterial/Anti-Inflammatory Therapy of Endophthalmitis. ACS applied materials & interfaces · 6 Aug 2026 PMID 42561041
  5. An integrated system of micromixers and microfluidic concentration gradient chips assisted drug screening over large concentration range. Mikrochimica acta · 18 Jul 2026 PMID 42471438
  6. A "three-in-one" nose-to-brain delivery strategy: intranasal vancomycin spray achieves simultaneous clearance of pneumococcal colonization, bacteremia, and meningitis. International journal of pharmaceutics · 4 Jul 2026 PMID 42401303
  7. Ultrasmall pH-triggered cerium-based MOF nanozyme delivery system: Stable implant coating with integrated synergistic antibacterial and corrosion resistance enhancement. Colloids and surfaces. B, Biointerfaces · 29 Jun 2026 PMID 42372462
  8. Injectable vancomycin-conjugated polysaccharide-protein hydrogel for targeted antibacterial therapy in musculoskeletal infections. International journal of biological macromolecules · 23 Jun 2026 PMID 42336007
  9. All-Hydrocarbon Stapling and Amino Acid Substitution-Modified Antimicrobial Peptide Feleucin-K3 Analogs Enhanced the Stability and Optimized the Therapeutic Index against Multidrug-Resistant Bacteria. Journal of medicinal chemistry · 9 Jun 2026 PMID 42262908
Unclassified: not yet indexed with MeSH (1)
  1. Risk of acute kidney injury in patients on concomitant vancomycin and piperacillin-tazobactam compared to vancomycin and other beta-lactam agents: a large multicenter retrospective cohort study from China. Microbiology spectrum · 6 Jul 2026 PMID 42405788